Med Chem Res
Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in
carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267
Kudo C, Yamakoshi H, Sato A, Nanjo H, Ohori H, Ishioka C, Iwabuchi
Y, Shibata H (2011) Synthesis of 86 species of 1, 5-diaryl-3-oxo-1,
4-pentadienes analogs of curcumin can yield a good lead in vivo.
Liang G, Shao L, Wang Y, Zhao C, Chu Y, Xiao J, Zhao Y, Li X,
Yang S (2009) Exploration and synthesis of curcumin analogs
with improved structural stability both in vitro and in vivo as
cytotoxic agents. Bioorg Med Chem 17:2623–2631
Liu GY, Zhai Q, Chen JZ, Zhang ZQ, Yang J (2016) 2,2′-Fluorine
mono-carbonyl curcumin induce reactive oxygen species-
mediated apoptosis in Human lung cancer NCI-H460 dells. Eur
J Pharmacol 786:161–168
Lopez J, Tait SW (2015) Mitochondrial apoptosis: killing cancer using
the enemy within. Br J Cancer 112:957–962
Morin D, Barthelemy S, Zini R, Labidalle S, Tillement JP (2001)
Curcumin induces the mitochondrial permeability transition pore
mediated by membrane protein thiol oxidation. FEBS Lett
495:131–136
Mosley CA, Liotta DC, Snyder JP (2007) Highly active anticancer
curcumin analogs. Adv Exp Med Biol 595:77–103
Nunes LM, Hossain M, Varela-Ramirez A, Das U, Ayala-Marin YM,
Dimmock JR, Aguilera RJ (2016) A novel class of piperidones
exhibit potent, selective and pro-apoptotic anti-leukemia proper-
ties. Oncol Lett 11:3824–3848
Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y,
Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C (2006)
Synthesis and biological analysis of new curcumin analogs
bearing an enhanced potential for the medicinal treatment of
cancer. Mol Cancer Ther 5:2563–2571
References
Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier
RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR (2004)
Synthesis and biological evaluation of novel curcumin analogs as
anti-cancer and anti-angiogenesis agents. Bioorg Med Chem
12:3871–3883
Adams BK, Cai JY, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP,
Liotta DC, Jones DP, Shoji M (2005) EF24, a novel synthetic
curcumin analog, induces apoptosis in cancer cells via a redox-
dependent mechanism. Anti-Cancer Drugs 16:263–275
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007)
Bioavailability of curcumin: problems and promises. Mol Pharm
4:807–818
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB
(2008a) Curcumin and cancer: an “old-age” disease with an “age-
old” solution. Cancer Lett 267:133–164
Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar
KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajase-
kharan KN, Aggarwal BB (2008b) Biological activities of cur-
cumin and its analogs (Congeners) made by man and mother
nature. Biochem Pharmacol 76:1590–1611
Anand P, Sung B, Kunnumakkara AB, Rajasekharan KN, Aggarwal
BB (2011) Suppression of pro-inflammatory and proliferative
pathways by diferuloylmethane (curcumin) and its analogs
dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone:
role of Michael acceptors and Michael donors. Biochem Phar-
macol 82:1901–1909
Chen WQ, Zou P, Zhao ZW, Chen X, Fan XX, Vinothkumar R, Cui R,
Wu FZ, Zhang QQ, Liang G (2016) Synergistic antitumor activity
of rapamycin and EF24 via increasing ROS for the treatment of
gastric cancer. Redox Biol 10:78–89
Chew EH, Nagle AA, Zhang Y, Scarmagnani S, Palaniappan P,
Bradshaw TD, Holmgren A, Westwell AD (2010) Cinnamalde-
hydes inhibit thioredoxin reductase and induce Nrf2: potential
candidates for cancer therapy and chemoprevention. Free Radic
Biol Med 48:98–111
Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and
therapeutic implications. Drug Resist Update 7:97–110
Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M (2008)
Modulation of anti-apoptotic and survival pathways by curcumin
as a strategy to induce apoptosis in cancer cells. Biochem Phar-
macol 76:1340–1351
Vandeputte C, Guizon I, Genestie-Denis I, Vannier B, Lorenzon G
(1994) A microtiter plate assay for total glutathione and glutathione
disulfide contents in cultured/isolated cells: performance study of a
new miniaturized protocol. Cell Biol Toxicol 10:415–421
Wang Y, Xiao J, Zhou H, Yang S, Wu X, Jiang C, Zhao Y, Liang D,
Li X, Liang G (2011) A novel monocarbonyl analog of curcumin,
(1 E, 4 E)-1, 5-bis (2, 3-dimethoxyphenyl) penta-1, 4-dien-3-one,
induced cancer cell H460 apoptosis via activation of endoplasmic
reticulum stress signaling pathway. J Med Chem 54:3768–3778
Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Vander Jagt DL
(2005) Anti-oxidant activities of curcumin and related enones.
Bioorg Med Chem 13:3811–3820
Wu JZ, Zhang YL, Cai YP, Wang J, Weng BX, Tang QQ, Chen XJ,
Pan ZE, Liang G, Yang SL (2013) Discovery and evaluation of
piperid-4-one-containing mono-carbonyl analogs of curcumin as
anti-inflammatory agents. Bioorg Med Chem 21:3058–3065
Wu JZ, Wu SB, Shi LY, Zhang SS, Ren JY, Yao S, Yun D, Huang LL,
Wang JB, Li WL, Wu XP, Qiu PH, Liang G (2017) Design,
synthesis, and evaluation of asymmetric EF24 analogs as poten-
tial anti-cancer agents for lung cancer. Eur J Med Chem
125:1321–1331
Dai F, Liu GY, Li Y, Yan WJ, Wang Q, Yang J, Lu DL, Lin D, Zhou
B (2015) Insights into the importance for designing curcumin-
inspired anticancer agents by a prooxidant strategy: the case of
diarylpentanoids. Free Radic Biol Med 85:127–137
Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P
(2001) Potency of Michael reaction acceptors as inducers of
enzymes that protect against carcinogenesis depends on their
reactivity with sulfhydryl groups. Proc Natl Acad Sci USA
98:3404–3409
Gan FF, Kaminska KK, Yang H, Liew CY, Leow PC, So CL, Tu LN,
Roy A, Yap CW, Kang TS (2013) Identification of Michael
acceptor-centric pharmacophores with substituents that yield
strong thioredoxin reductase inhibitory character correlated to
antiproliferative activity. Antioxid Redox Signal 19:1149–1165
Goel A, Jhurani S, Aggarwal BB (2008) Muti-targeted therapy by
curcumin: how spicy is it? Mol Nutr Food Res 52:1010–1030
Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadasini IK,
Aggarwal BB (2011) Multitargeting by curcumin as revealed by
molecular interaction studies. Nat Prod Res 28:1937–1955
Hagmann WK (2008) The many roles for fluorine in medicinal
chemistry. J Med Chem 51:4359–4369
Yamakoshi H, Ohori H, Kudo C, Sato A, Kanoh N, Ishioka C, Shibata
H, Iwabuchi Y (2010) Structure–activity relationship of C5-
curcuminoids and synthesis of their molecular probes thereof.
Bioorg Med Chem 18:1083–1092
Zou P, Xia YQ, Chen WQ, Chen X, Ying SL, Feng ZG, Chen TK, Ye
QQ, Wang Z, Qiu CY, Yang SL, Liang G (2016) EF24 induces
ROS-mediated apoptosis via targeting thioredoxin reductase 1 in
gastric cancer cells. Oncotarget 7:18050–18064
ICH Harmonized Tripartite Guideline, Q1A(R2) (2003) Stability
testing for new drug substance and products
Kia Y, Osman H, Kumar RS, Murugaiyah V, Basiri A, Perumal S,
Wahab HA, Bing CS (2013) Synthesis and discovery of novel
piperidone-grafted mono- and bis-spirooxindole-hexahydropyrro-
lizines as potent cholinesterase inhibitors. Bioorg Med Chem
21:1696–1707